Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain.

Hefner K, Whittle N, Juhasz J, Norcross M, Karlsson RM, Saksida LM, Bussey TJ, Singewald N, Holmes A.

J Neurosci. 2008 Aug 6;28(32):8074-85. doi: 10.1523/JNEUROSCI.4904-07.2008.

2.

Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.

Bauer D, Gupta D, Harotunian V, Meador-Woodruff JH, McCullumsmith RE.

Schizophr Res. 2008 Sep;104(1-3):108-20. doi: 10.1016/j.schres.2008.06.012. Epub 2008 Aug 3.

3.
4.

Visual perception and its impairment in schizophrenia.

Butler PD, Silverstein SM, Dakin SC.

Biol Psychiatry. 2008 Jul 1;64(1):40-7. doi: 10.1016/j.biopsych.2008.03.023.

5.

The cognitive neuroscience of memory function and dysfunction in schizophrenia.

Ranganath C, Minzenberg MJ, Ragland JD.

Biol Psychiatry. 2008 Jul 1;64(1):18-25. doi: 10.1016/j.biopsych.2008.04.011. Epub 2008 May 21.

6.

Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative.

Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, Geyer M, Green M, Nuechterlein KH, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R.

Biol Psychiatry. 2008 Jul 1;64(1):4-10. doi: 10.1016/j.biopsych.2008.03.020. Epub 2008 May 7.

7.

Glutamate transporters regulate lesion-induced plasticity in the developing somatosensory cortex.

Takasaki C, Okada R, Mitani A, Fukaya M, Yamasaki M, Fujihara Y, Shirakawa T, Tanaka K, Watanabe M.

J Neurosci. 2008 May 7;28(19):4995-5006. doi: 10.1523/JNEUROSCI.0861-08.2008.

8.

Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Holmes A.

Neurosci Biobehav Rev. 2008 Sep;32(7):1293-314. doi: 10.1016/j.neubiorev.2008.03.006. Epub 2008 Mar 26. Review.

9.

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.

Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J.

Science. 2008 Apr 25;320(5875):539-43. doi: 10.1126/science.1155174. Epub 2008 Mar 27.

10.

Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit.

Brigman JL, Feyder M, Saksida LM, Bussey TJ, Mishina M, Holmes A.

Learn Mem. 2008 Jan 28;15(2):50-4. doi: 10.1101/lm.777308. Print 2008 Feb.

11.

Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice.

Bechtholt AJ, Smith K, Gaughan S, Lucki I.

Physiol Behav. 2008 Mar 18;93(4-5):659-65. Epub 2007 Nov 9.

12.
13.

Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions.

Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ.

Cell. 2007 Oct 19;131(2):391-404.

14.

Mouse behavioral assays relevant to the symptoms of autism.

Crawley JN.

Brain Pathol. 2007 Oct;17(4):448-59. Review.

PMID:
17919130
15.

Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.

Kargieman L, Santana N, Mengod G, Celada P, Artigas F.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14843-8. Epub 2007 Sep 4.

16.

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.

Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD.

Nat Med. 2007 Sep;13(9):1102-7. Epub 2007 Sep 2. Erratum in: Nat Med. 2007 Oct;13(10):1264.

PMID:
17767166
17.
18.

Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cbeta1.

Koh HY, Kim D, Lee J, Lee S, Shin HS.

Genes Brain Behav. 2008 Feb;7(1):120-8. Epub 2007 Aug 13.

19.

Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors.

Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson RM, Hefner K, Sprengel R, Celikel T, Daws LC, Holmes A.

Mol Psychiatry. 2008 Jun;13(6):631-40. Epub 2007 Aug 7.

PMID:
17684498
20.

Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.

Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andradé M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A.

Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14501-6. Epub 2007 Aug 3.

Supplemental Content

Support Center